Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (8389)	5/17/2003 10:11:04 PM
From: tom pope	Respond to of 52153

This is what convertbond.com shows - For zeroes and OID's The following 6 Convertible(s) meet your search criteria: Security Type: Zero/OID Industry: Biotechnology -- Select a Portfolio -- Ticker Issuer Cpn($/%) Maturity ConvPrice($/%) StockPrice($) Curr Yld (%) YTP/M (%) Prem (%) Brk Even (Yrs) Yrs To Call Rich/ Cheap (%) Prem Over IV (%) Delta (%) Mdys S&P Amt. O/S ($mil) ALO ALPHARMA INC 3.000 6/1/06 111.750 19.92 2.68 8.8 80.1 19.3 0.0 -0.64 3.2 19.18 NR B 116 AMGN AMGEN (2821 NET) 0.000 3/1/32 78.250 62.31 0.00 0.9 41.7 0.0 3.8 4.18 10.0 33.28 A2 A 3,950 CHIR CHIRON CORP 0.000 6/12/31 58.750 41.05 0.00 1.9 99.8 0.0 3.1 1.76 2.6 10.54 Baa1 A- 730 IDPH IDEC PHARM 1 (117 NET) 0.000 2/16/19 139.875 34.18 0.00 -2.1 1.3 0.0 0.8 1.27 232.8 100.03 NR NR 345 IDPH IDEC PHARM 2 (714 NET) 0.000 4/29/32 58.625 34.18 0.00 3.3 138.6 0.0 4.0 2.14 4.2 16.10 NR BB 1,205 DNA ROCHE/GENENTECH (1000 NET)* and for bonds: ABGX ABGENIX 3.500 3/15/07 84.625 11.18 4.14 8.4 108.7 12.6 0.0 1.20 8.6 31.11 NR NR 200 AFFX AFFYMETRIX 5.000 10/1/06 97.125 20.93 5.15 6.0 185.4 12.6 0.0 4.07 6.8 11.69 NR CCC+ 150 AFFX AFFYMETRIX NEW 4.750 2/15/07 91.375 20.93 5.20 7.6 600.7 16.5 0.0 14.96 19.3 16.07 NR CCC+ 220 ALXN ALEXION PHARMACEUTICALS 5.750 3/15/07 75.625 13.84 7.60 14.7 481.5 10.9 0.0 -0.20 -0.1 2.03 NR NR 120 ALKS ALKERMES NEW 6.520 12/31/07 162.625 11.27 4.01 -5.2 10.9 2.4 10.52 72.4 67.79 NR NR 173 MEDI AVIRON 2 / MEDIMMUNE 5.250 2/1/08 105.000 34.32 5.00 4.1 77.9 8.8 0.7 4.14 13.5 32.82 NR NR 200 CEPH CEPHALON 5.250 5/1/06 103.250 42.42 5.08 4.1 80.1 8.7 0.0 4.88 9.7 20.87 NR NR 183 CEPH CEPHALON 2 2.500 12/15/06 93.875 42.42 2.66 4.4 79.3 16.6 1.6 6.19 12.9 28.17 NR NR 600 CRGN CURAGEN 6.000 2/2/07 75.875 4.26 7.91 15.2 1,036.8 11.5 0.0 -0.10 -0.1 0.99 NR CCC 150 CVTX CV THERAPEUTICS 4.750 3/7/07 88.875 23.68 5.34 8.4 139.6 10.9 0.0 -3.28 -0.1 17.94 NR NR 196 EW EDWARDS LIFESCIENCES* GENZ GENZYME-GENL DIV 2 3.000 5/15/21 103.250 43.16 2.91 2.8 68.2 14.0 1.0 5.16 11.1 26.77 NR BB+ 575 GILD GILEAD SCIENCES 5.000 12/15/07 198.625 47.45 2.52 -10.7 2.8 1.1 0.6 1.15 102.2 97.78 NR NR 250 GILD GILEAD SCIENCES 2* HGSI HUMAN GENOME 3 5.000 2/1/07 87.500 13.97 5.71 9.2 252.3 12.5 0.0 3.93 6.2 15.84 NR CCC 200 HGSI HUMAN GENOME 4 3.750 3/15/07 80.375 13.97 4.67 10.3 530.0 18.0 0.0 2.53 3.1 7.76 NR CCC 300 IMCLE IMCLONE SYSTEMS 5.500 3/1/05 93.250 21.20 5.90 9.9 142.3 10.0 0.0 -3.39 -0.0 20.84 NR NR 240 INCY INCYTE PHARMA (GENOMICS) 5.500 2/1/07 71.625 3.90 7.68 16.5 1,138.2 12.0 0.0 -0.19 -0.1 3.77 NR CCC+ 177 NKTR INHALE/NEKTAR THERAPEUTIC 2 5.000 2/8/07 66.750 7.78 7.49 18.3 229.3 9.3 0.0 -2.72 -0.1 17.99 NR NR 61 NKTR INHALE/NEKTAR THERAPEUTIC 3 3.500 10/17/07 60.750 7.78 5.76 17.0 294.3 13.0 0.0 -3.08 -0.2 22.19 NR NR 230 IART INTEGRA LIFE* IVGN INVITROGEN 5.500 3/1/07 100.750 36.14 5.46 5.3 137.5 10.6 0.0 3.30 5.4 16.04 NR NR 173 IVGN INVITROGEN 2 2.250 12/15/06 92.000 36.14 2.45 4.8 119.2 22.2 2.6 5.63 8.2 17.75 NR NR 500 MEDX MEDAREX 4.500 7/1/06 76.625 5.02 5.87 14.5 340.2 13.2 0.0 -0.70 -0.1 7.87 NR NR 175 MLNM MILLENNIUM PHARMACEUTICALS 5.500 1/15/07 95.000 14.23 5.79 7.2 180.9 11.1 0.0 -2.16 0.7 15.68 NR CCC+ 96 PDLI PROTEIN DESIGN LABS 5.500 2/15/07 96.875 11.65 5.68 6.5 213.9 12.0 0.0 3.99 5.5 11.29 NR CCC 150 SEPR SEPRACOR 2 7.000 12/15/05 97.625 20.61 7.17 8.2 195.8 9.2 0.0 7.74 12.7 23.43 NR CCC+ 112 SEPR SEPRACOR 3 5.000 2/15/07 82.625 20.61 6.05 11.0 270.4 12.1 0.0 5.61 10.1 27.12 NR CCC+ 440 SEPR SEPRACOR 4 5.750 11/15/06 87.875 20.61 6.54 10.2 155.8 9.3 0.0 2.66 11.8 40.97 NR CCC+ 430 UTSI UTSTARCOM* VRTX VERTEX PHARMACEUTICALS NEW 5.000 9/19/07 83.875 13.50 5.96 9.9 473.2 13.8 0.0 -0.38 -0.2 4.58 NR NR 315 VPHM VIROPHARMA 6.000 3/1/07 50.250 3.35 11.94 30.2 1,537.2 7.9 0.0 -0.70 -0.2 15.65 NR NR 135